Congratulations to AxCynsis Therapeutics, a TIBS-invested and incubated company, awarded “Top 5 Biotech Startups in Singapore 2022” by STARTUP CITY.

Founder and CEO, Dr Zou Bin has shared how AxCynsis will transform the course of cancer treatments to benefit patients. Please find more here.

AxCynsis Therapeutics was the first Singapore company incubated by TIBS in March 2022 with US$ 15M invested.